Evaluation Of Combined Metformin-Lovastatin Therapy In The Treatment Of Diabetic Type 2 Patients With Dyslipidemia In Hospital Pulau Pinang

Diabetes type 2 is characterized by the presence of insulin resistance which frequently co-exists with multiple cardiovascular risk factors. Dyslipidemia is a well-recognized and modifiable risk factor that should be identified and treated aggressively to prevent the onset and prognosis of cardio...

Full description

Saved in:
Bibliographic Details
Main Author: Ghaith, Nada Faisal Zaki
Format: Thesis
Language:English
Published: 2010
Subjects:
Online Access:http://eprints.usm.my/41689/1/Nada_Faisal_HJ.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id my-usm-ep.41689
record_format uketd_dc
spelling my-usm-ep.416892019-04-12T05:26:58Z Evaluation Of Combined Metformin-Lovastatin Therapy In The Treatment Of Diabetic Type 2 Patients With Dyslipidemia In Hospital Pulau Pinang 2010 Ghaith, Nada Faisal Zaki RS1-441 Pharmacy and materia medica Diabetes type 2 is characterized by the presence of insulin resistance which frequently co-exists with multiple cardiovascular risk factors. Dyslipidemia is a well-recognized and modifiable risk factor that should be identified and treated aggressively to prevent the onset and prognosis of cardiovascular disease. This study aimed to assess the clinical outcomes behind the usage of metformin and lovastatin in the treatment of diabetes type 2 patients with dyslipidemia. Furthermore, an evaluation of difference in therapeutic response was done according to race and gender. A retrospective observational study was performed at the outpatient clinic of Hospital Pulau Pinang, Malaysia. Demographic, medication profile, and laboratory tests information were collected. Data were analyzed by using Statistical Package of Social Sciences (SPSS) program version 15. From 873 medical records, only 501 patients met the inclusion criteria of this study. Females constituted 55.9%, while 44.1% were males. Racial distribution showed that Chinese were 41.7%, Malay 34.3% and Indians 24%. Significantly, Chinese showed the highest percentage (97.5%) of controlled HDL levels. Unlike males, females demonstrated the highest mean TC and HDL values (5.40 ± 1.09 mmol/l and 1.32 ± 0.29 mmol/l respectively) significantly. 2010 Thesis http://eprints.usm.my/41689/ http://eprints.usm.my/41689/1/Nada_Faisal_HJ.pdf application/pdf en public masters Universiti Sains Malaysia Pusat Pengajian Sains Farmasi
institution Universiti Sains Malaysia
collection USM Institutional Repository
language English
topic RS1-441 Pharmacy and materia medica
spellingShingle RS1-441 Pharmacy and materia medica
Ghaith, Nada Faisal Zaki
Evaluation Of Combined Metformin-Lovastatin Therapy In The Treatment Of Diabetic Type 2 Patients With Dyslipidemia In Hospital Pulau Pinang
description Diabetes type 2 is characterized by the presence of insulin resistance which frequently co-exists with multiple cardiovascular risk factors. Dyslipidemia is a well-recognized and modifiable risk factor that should be identified and treated aggressively to prevent the onset and prognosis of cardiovascular disease. This study aimed to assess the clinical outcomes behind the usage of metformin and lovastatin in the treatment of diabetes type 2 patients with dyslipidemia. Furthermore, an evaluation of difference in therapeutic response was done according to race and gender. A retrospective observational study was performed at the outpatient clinic of Hospital Pulau Pinang, Malaysia. Demographic, medication profile, and laboratory tests information were collected. Data were analyzed by using Statistical Package of Social Sciences (SPSS) program version 15. From 873 medical records, only 501 patients met the inclusion criteria of this study. Females constituted 55.9%, while 44.1% were males. Racial distribution showed that Chinese were 41.7%, Malay 34.3% and Indians 24%. Significantly, Chinese showed the highest percentage (97.5%) of controlled HDL levels. Unlike males, females demonstrated the highest mean TC and HDL values (5.40 ± 1.09 mmol/l and 1.32 ± 0.29 mmol/l respectively) significantly.
format Thesis
qualification_level Master's degree
author Ghaith, Nada Faisal Zaki
author_facet Ghaith, Nada Faisal Zaki
author_sort Ghaith, Nada Faisal Zaki
title Evaluation Of Combined Metformin-Lovastatin Therapy In The Treatment Of Diabetic Type 2 Patients With Dyslipidemia In Hospital Pulau Pinang
title_short Evaluation Of Combined Metformin-Lovastatin Therapy In The Treatment Of Diabetic Type 2 Patients With Dyslipidemia In Hospital Pulau Pinang
title_full Evaluation Of Combined Metformin-Lovastatin Therapy In The Treatment Of Diabetic Type 2 Patients With Dyslipidemia In Hospital Pulau Pinang
title_fullStr Evaluation Of Combined Metformin-Lovastatin Therapy In The Treatment Of Diabetic Type 2 Patients With Dyslipidemia In Hospital Pulau Pinang
title_full_unstemmed Evaluation Of Combined Metformin-Lovastatin Therapy In The Treatment Of Diabetic Type 2 Patients With Dyslipidemia In Hospital Pulau Pinang
title_sort evaluation of combined metformin-lovastatin therapy in the treatment of diabetic type 2 patients with dyslipidemia in hospital pulau pinang
granting_institution Universiti Sains Malaysia
granting_department Pusat Pengajian Sains Farmasi
publishDate 2010
url http://eprints.usm.my/41689/1/Nada_Faisal_HJ.pdf
_version_ 1747820956841148416